{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:11:53Z","timestamp":1790190713917,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002449","name":"Jeju National University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","jocn-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jocn.2018.01.047","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T17:49:44Z","timestamp":1517507384000},"page":"294-297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Low serum vitamin D levels in patients with myasthenia gravis"],"prefix":"10.1016","volume":"50","author":[{"given":"Sa-Yoon","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hoon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay Chol","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sook Keun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Hwan","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2018.01.047_b0005","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","article-title":"Functional defect of regulatory CD4(+)CD25+T cells in the thymus of patients with autoimmune myasthenia gravis","volume":"105","author":"Balandina","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jocn.2018.01.047_b0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.clim.2012.09.012","article-title":"Impaired regulatory function in circulating CD4(+)CD25(high)CD127(low\/-)T cells in patients with myasthenia gravis","volume":"145","author":"Thiruppathi","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jocn.2018.01.047_b0015","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.4049\/jimmunol.0803217","article-title":"1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3","volume":"183","author":"Jeffery","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jocn.2018.01.047_b0020","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1002\/eji.201242370","article-title":"The role of 1alpha 25-dihydroxyvitamin D3 and cytokines in the promotion of distinct FoxP3+ and IL-10+ CD4+ T cells","volume":"42","author":"Urry","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jocn.2018.01.047_b0025","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/0961203311422094","article-title":"Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q","volume":"21","author":"Mok","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.jocn.2018.01.047_b0030","first-page":"714","article-title":"Determinants and effects of vitamin D supplementation on serum 25-hydroxyvitamin D levels in patients with rheumatoid arthritis","volume":"30","author":"Varenna","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jocn.2018.01.047_b0035","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1177\/1352458508094399","article-title":"Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis","volume":"14","author":"Smolders","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.jocn.2018.01.047_b0040","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.autrev.2011.05.004","article-title":"Human FoxP3+ regulatory T cells in systemic autoimmune diseases","volume":"10","author":"Miyara","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jocn.2018.01.047_b0045","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4049\/jimmunol.174.1.164","article-title":"Dysfunctional blood and target tissue CD4+CD25 high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation","volume":"174","author":"Sugiyama","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jocn.2018.01.047_b0050","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis","volume":"199","author":"Viglietta","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.jocn.2018.01.047_b0055","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/imm.12289","article-title":"1alpha,25-dihydroxyvitamin D3 in combination with transforming growth factor-beta increases the frequency of Foxp3(+) regulatory T cells through preferential expansion and usage of interleukin-2","volume":"143","author":"Chambers","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.jocn.2018.01.047_b0060","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0165-2478(93)90088-J","article-title":"1,25-Dihydroxyvitamin D3 selectively reduces interleukin-2 levels and proliferation of human T cell lines in vitro","volume":"35","author":"Muller","year":"1993","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jocn.2018.01.047_b0065","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.4049\/jimmunol.0903183","article-title":"Naturally occurring CD4+CD25+ regulatory T cells prevent but do not improve experimental myasthenia gravis","volume":"185","author":"Nessi","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jocn.2018.01.047_b0070","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1111\/j.1468-1331.2012.03773.x","article-title":"Vitamin D deficiency in patients with myasthenia gravis and improvement of fatigue after supplementation of vitamin D3: a pilot study","volume":"19","author":"Askmark","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jocn.2018.01.047_b0075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s13760-015-0512-2","article-title":"Low vitamin D levels in healthy controls and patients with autoimmune neuromuscular disorders in Greece","volume":"116","author":"Chroni","year":"2016","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.jocn.2018.01.047_b0080","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jneuroim.2015.03.008","article-title":"Regulatory function of CD4+CD25++T cells in patients with myasthenia gravis is associated with phenotypic changes and STAT5 signaling: 1,25-Dihydroxyvitamin D3 modulates the suppressor activity","volume":"281","author":"Alahgholi-Hajibehzad","year":"2015","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jocn.2018.01.047_b0085","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/nan.12020","article-title":"Review: the role of vitamin D in nervous system health and disease","volume":"39","author":"DeLuca","year":"2013","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.jocn.2018.01.047_b0090","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/archneurol.2011.30","article-title":"High prevalence of hypovitaminosis D status in patients with early Parkinson disease","volume":"68","author":"Evatt","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jocn.2018.01.047_b0095","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1212\/WNL.0000000000000755","article-title":"Vitamin D and the risk of dementia and Alzheimer disease","volume":"83","author":"Littlejohns","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2018.01.047_b0100","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.jocn.2013.01.011","article-title":"Vitamin D deficiency and its supplementation in patients with amyotrophic lateral sclerosis","volume":"20","author":"Karam","year":"2013","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jocn.2018.01.047_b0105","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/ene.12731","article-title":"Vitamin D, vitamin D binding protein gene polymorphisms, race and risk of incident stroke: the Atherosclerosis Risk in Communities (ARIC) study","volume":"22","author":"Schneider","year":"2015","journal-title":"Eur J Neurol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586817314169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586817314169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T09:29:05Z","timestamp":1535102945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586817314169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":21,"alternative-id":["S0967586817314169"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2018.01.047","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low serum vitamin D levels in patients with myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2018.01.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}